Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department
Open accessThe DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) is increasingly recognized in infections among persons in the community without established risk factors for MRSA. METHODS: We enrolled adult patients with acute, purulent skin and soft-tissue infections presenting to 11 university-affiliated emergency departments during the month of August 2004. Cultures were obtained, and clinical information was collected. Available S. aureus isolates were characterized by antimicrobial-susceptibility testing, pulsed-field gel electrophoresis, and detection of toxin genes. On MRSA isolates, we performed typing of the staphylococcal cassette chromosome mec (SCCmec), the genetic element that carries the mecA gene encoding methicillin resistance. RESULTS: S. aureus was isolated from 320 of 422 patients with skin and soft-tissue infections (76 percent). The prevalence of MRSA was 59 percent overall and ranged from 15 to 74 percent. Pulsed-field type USA300 isolates accounted for 97 percent of MRSA isolates; 74 percent of these were a single strain (USA300-0114). SCCmec type IV and the Panton-Valentine leukocidin toxin gene were detected in 98 percent of MRSA isolates. Other toxin genes were detected rarely. Among the MRSA isolates, 95 percent were susceptible to clindamycin, 6 percent to erythromycin, 60 percent to fluoroquinolones, 100 percent to rifampin and trimethoprim-sulfamethoxazole, and 92 percent to tetracycline. Antibiotic therapy was not concordant with the results of susceptibility testing in 100 of 175 patients with MRSA infection who received antibiotics (57 percent). Among methicillin-susceptible S. aureus isolates, 31 percent were USA300 and 42 percent contained pvl genes. CONCLUSIONS: MRSA is the most common identifiable cause of skin and soft-tissue infections among patients presenting to emergency departments in 11 U.S. cities. When antimicrobial therapy is indicated for the treatment of skin and soft-tissue infections, clinicians should consider obtaining cultures and modifying empirical therapy to provide MRSA coverage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A recently published study of 422 patients with SSTI from 11 EDs in the United States reported that the prevalence of MRSA was 59%. 15”
From Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in a Canadian emergency department (2009) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“In other research, IDU was strongly linked to MRSA SSTI in homeless individuals, 7 but this association was not found in 2 ED-based studies. 8,15”
From Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in a Canadian emergency department (2009) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lina, G., Piemont, Y., Godail-Gamot, F., Bes, M., Peter, M.-O., Gauduchon, V., Vandenesch, F., & Etienne, J. (1999) · Clinical Infectious Diseases · doi:10.1086/313461 · Cited by 2,489
Naimi, T. S. (2003) · JAMA · doi:10.1001/jama.290.22.2976 · Cited by 1,688
Methicillin-Resistant Staphylococcus aureus Disease in Three Communities
Fridkin, S. K., Hageman, J. C., Morrison, M., Sanza, L. T., Como-Sabetti, K., Jernigan, J. A., Harriman, K., Harrison, L. H., Lynfield, R., & Farley, M. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043252 · Cited by 1,493
Herold, B. C. (1998) · JAMA · doi:10.1001/jama.279.8.593 · Cited by 1,412
McDougal, L. K., Steward, C. D., Killgore, G. E., Chaitram, J. M., McAllister, S. K., & Tenover, F. C. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.5113-5120.2003 · Cited by 1,399
Self-citationA Clone of Methicillin-Resistant Staphylococcus aureus among Professional Football Players
Kazakova, S. V., Hageman, J. C., Matava, M., Srinivasan, A., Phelan, L., Garfinkel, B., Boo, T., McAllister, S., Anderson, J., Jensen, B., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042859 · Cited by 741
Self-citationFrancis, J. S., Doherty, M. C., Lopatin, U., Johnston, C. P., Sinha, G., Ross, T., Cai, M., Hansel, N. N., Perl, T., Ticehurst, J. R., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/427148 · Cited by 719
Barrett, F. F., McGehee, R. F., & Finland, M. (1968) · New England Journal of Medicine · doi:10.1056/nejm196808292790901 · Cited by 512
Frazee, B. W., Lynn, J., Charlebois, E. D., Lambert, L., Lowery, D., & Perdreau-Remington, F. (2005) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2004.10.011 · Cited by 494
Linezolid versus Vancomycin in Treatment of Complicated Skin and Soft Tissue Infections
Weigelt, J., Itani, K., Stevens, D., Lau, W., Dryden, M., & Knirsch, C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2260-2266.2005 · Cited by 457
Research works printed but not linked: 3
- 2003, MMWR Morb Mortal Wkly Rep, 52, 88
- Bannerman TL. Staphylococci and other catalase positive cocci that grow aerobically. In: Murray PR, Baron EJ, Jogensen JH, eds. Manual of clinical microbiology. 8th ed. Washington, D.C.: ASM Press, 2003:384-404.
- 10.1097/00006454-200307000-00006 · doi:10.1097/00006454-200307000-00006
Cited by
Items 101–200 of 1,001
Community‐Associated Methicillin‐Resistant Staphylococcus aureus
Weber, J. T. (2005) · Clinical Infectious Diseases · doi:10.1086/430788 · Cited by 244
Trimethoprim–Sulfamethoxazole versus Placebo for Uncomplicated Skin Abscess
Talan, D. A., Mower, W. R., Krishnadasan, A., Abrahamian, F. M., Lovecchio, F., Karras, D. J., Steele, M. T., Rothman, R. E., Hoagland, R., & Moran, G. J. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1507476 · Cited by 236
Self-citationPaharik, A. E., Parlet, C. P., Chung, N., Todd, D. A., Rodriguez, E. I., Van Dyke, M. J., Cech, N. B., & Horswill, A. R. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.11.001 · Cited by 244
Pantosti, A. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00127 · Cited by 239
“In the USA, the increase in the prevalence of CA-MRSA took the shape of an epidemic, largely due to the expansion of a single clone, designated USA300 (Moran et al., 2006; Kennedy et al., 2008; Tenover and Goering, 2009).”
BackgroundSurgical site infections after cesarean delivery: epidemiology, prevention and treatment
Kawakita, T., & Landy, H. J. (2017) · Maternal Health, Neonatology and Perinatology · doi:10.1186/s40748-017-0051-3 · Cited by 237
“If purulent drainage or exudates accompany cellulitis, empiric therapy should include adequate coverage for methicillin-resistant Staphylococcus aureus (MRSA) [70].”
BackgroundWardenburg, J. B., Palazzolo‐Ballance, A. M., Otto, M., Schneewind, O., & DeLeo, F. R. (2008) · The Journal of Infectious Diseases · doi:10.1086/592053 · Cited by 236
Methicillin-resistant Staphylococcus aureus: the European landscape
Johnson, A. P. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr076 · Cited by 221
García-Arias, M., Balsa, A., & Mola, E. M. (2011) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2011.02.001 · Cited by 219
Molecular Pathogenesis of Staphylococcus aureus Infection
Liu, G. Y. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31819dc44d · Cited by 220
Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Asia
Chuang, Y.-Y., & Huang, Y.-C. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70136-1 · Cited by 219
Risk of Infection and Death due to Methicillin‐Resistant Staphylococcus aureus in Long‐Term Carriers
Datta, R., & Huang, S. S. (2008) · Clinical Infectious Diseases · doi:10.1086/589241 · Cited by 222
The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)
Lee, B. Y., Singh, A., David, M. Z., Bartsch, S. M., Slayton, R. B., Huang, S. S., Zimmer, S. M., Potter, M. A., Macal, C. M., Lauderdale, D. S., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03914.x · Cited by 207
Nathwani, D., Morgan, M., Masterton, R. G., Dryden, M., Cookson, B. D., French, G., & Lewis, D. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn096 · Cited by 217
Skin Infections Caused by Staphylococcus aureus
Giudice, P. (2020) · Acta Dermato Venereologica · doi:10.2340/00015555-3466 · Cited by 182
Ventura, C. L., Malachowa, N., Hammer, C. H., Nardone, G. A., Robinson, M. A., Kobayashi, S. D., & DeLeo, F. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011634 · Cited by 204
Wolk, D. M., Struelens, M. J., Pancholi, P., Davis, T., Della-Latta, P., Fuller, D., Picton, E., Dickenson, R., Denis, O., Johnson, D., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01884-08 · Cited by 214
Wilcox, M. H., Corey, G. R., Talbot, G. H., Thye, D., Friedland, D., Baculik, T., on behalf of the CANVAS 2 investigators, Manos, P., Lee, P., Bush, L., et al. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq255 · Cited by 216
Rajendran, P. M., Young, D., Maurer, T., Chambers, H., Perdreau-Remington, F., Ro, P., & Harris, H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00377-07 · Cited by 214
Ruhe, J. J., Smith, N., Bradsher, R. W., & Menon, A. (2007) · Clinical Infectious Diseases · doi:10.1086/511872 · Cited by 214
Drug interactions modulate the potential for evolution of resistance
Michel, J.-B., Yeh, P. J., Chait, R., Moellering, R. C., & Kishony, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800944105 · Cited by 215
Rapid bactericidal action of alpha-mangostin against MRSA as an outcome of membrane targeting
Koh, J.-J., Qiu, S., Zou, H., Lakshminarayanan, R., Li, J., Zhou, X., Tang, C., Saraswathi, P., Verma, C., Tan, D. T. H., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.09.004 · Cited by 212
Genetics of Antimicrobial Resistance in Staphylococcus Aureus
Jensen, S. O., & Lyon, B. R. (2009) · Future Microbiology · doi:10.2217/fmb.09.30 · Cited by 202
Dohin, B., Gillet, Y., Kohler, R., Lina, G., Vandenesch, F., Vanhems, P., Floret, D., & Etienne, J. (2007) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e318133a85e · Cited by 209
Skin and Soft-Tissue Infections: A Critical Review and the Role of Telavancin in Their Treatment
Cardona, A. F., & Wilson, S. E. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ528 · Cited by 207
Duong, M., Markwell, S., Peter, J., & Barenkamp, S. (2010) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2009.03.014 · Cited by 210
Liu, C., Graber, C. J., Karr, M., Diep, B. A., Basuino, L., Schwartz, B. S., Enright, M. C., O’Hanlon, S. J., Thomas, J. C., Perdreau‐Remington, F., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/587893 · Cited by 205
“Many studies characterizing community-associated MRSA and the USA300 strain have focused on outbreaks in particular groups [12–16] or among people presenting with skin and soft-tissue infection [7, 17].”
BackgroundClindamycin versus Trimethoprim–Sulfamethoxazole for Uncomplicated Skin Infections
Miller, L. G., Daum, R. S., Creech, C. B., Young, D., Downing, M. D., Eells, S. J., Pettibone, S., Hoagland, R. J., & Chambers, H. F. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1403789 · Cited by 203
Musculoskeletal Infection: Role of CT in the Emergency Department
Fayad, L. M., Carrino, J. A., & Fishman, E. K. (2007) · RadioGraphics · doi:10.1148/rg.276075033 · Cited by 207
A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses
Daum, R. S., Miller, L. G., Immergluck, L., Fritz, S., Creech, C. B., Young, D., Kumar, N., Downing, M., Pettibone, S., Hoagland, R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1607033 · Cited by 204
Rice, L. B. (2008) · Clinical Infectious Diseases · doi:10.1086/526535 · Cited by 200
Epidemiology and microbiology of skin and soft tissue infections
Esposito, S., Noviello, S., & Leone, S. (2016) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000239 · Cited by 202
“Moreover, SCCmec type IV and the PVL gene were found in 98% of MRSA strains [15].”
BackgroundIncidence of skin and soft tissue infections in ambulatory and inpatient settings, 2005–2010
Miller, L. G., Eisenberg, D. F., Liu, H., Chang, C.-L., Wang, Y., Luthra, R., Wallace, A., Fang, C., Singer, J., & Suaya, J. A. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1071-0 · Cited by 192
Key Role for Clumping Factor B in Staphylococcus aureus Nasal Colonization of Humans
Wertheim, H. F. L., Walsh, E., Choudhurry, R., Melles, D. C., Boelens, H. A. M., Miajlovic, H., Verbrugh, H. A., Foster, T., & van Belkum, A. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050017 · Cited by 195
Noskin, G. A., Rubin, R. J., Schentag, J. J., Kluytmans, J., Hedblom, E. C., Jacobson, C., Smulders, M., Gemmen, E., & Bharmal, M. (2007) · Clinical Infectious Diseases · doi:10.1086/522186 · Cited by 200
Rehse, S. J., Salimnia, H., & Miziolek, A. W. (2012) · Journal of Medical Engineering & Technology · doi:10.3109/03091902.2011.645946 · Cited by 201
What Is Community‐Associated Methicillin‐Resistant Staphylococcus aureus?
David, M. Z., Glikman, D., Crawford, S. E., Peng, J., King, K. J., Hostetler, M. A., Boyle‐Vavra, S., & Daum, R. S. (2008) · The Journal of Infectious Diseases · doi:10.1086/533502 · Cited by 203
Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis
Parkins, M. D., & Floto, R. A. (2015) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2015.03.012 · Cited by 193
Davis, S. L., Perri, M. B., Donabedian, S. M., Manierski, C., Singh, A., Vager, D., Haque, N. Z., Speirs, K., Muder, R. R., Robinson-Dunn, B., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02311-06 · Cited by 196
New Perspectives in Biofilm Eradication
Wolfmeier, H., Pletzer, D., Mansour, S. C., & Hancock, R. E. W. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00170 · Cited by 200
Calfee, D. P., Salgado, C. D., Milstone, A. M., Harris, A. D., Kuhar, D. T., Moody, J., Aureden, K., Huang, S. S., Maragakis, L. L., & Yokoe, D. S. (2014) · Infection Control & Hospital Epidemiology · doi:10.1086/676534 · Cited by 193
Invasive Methicillin-Resistant Staphylococcus aureus Infections in the United States
Kumar, A. (2008) · Yearbook of Critical Care Medicine · doi:10.1016/s0734-3299(08)70527-6 · Cited by 197
Polymer‐Based Nitric Oxide Therapies: Recent Insights for Biomedical Applications
Jen, M. C., Serrano, M. C., van Lith, R., & Ameer, G. A. (2012) · Advanced Functional Materials · doi:10.1002/adfm.201101707 · Cited by 194
Evolution of community- and healthcare-associated methicillin-resistant Staphylococcus aureus
Uhlemann, A.-C., Otto, M., Lowy, F. D., & DeLeo, F. R. (2014) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2013.04.030 · Cited by 194
“In addition, resistance to fluoroquinolones, conferred by chromosomal mutations, continues to be on the rise (Moran et al., 2006; Talan et al., 2011).”
BackgroundInfluentialMedical Aspects of Spider Bites
Vetter, R. S., & Isbister, G. K. (2008) · Annual Review of Entomology · doi:10.1146/annurev.ento.53.103106.093503 · Cited by 186
Gerber, J. S., Coffin, S. E., Smathers, S. A., & Zaoutis, T. E. (2009) · Clinical Infectious Diseases · doi:10.1086/599348 · Cited by 193
Noel, G. J., Strauss, R. S., Amsler, K., Heep, M., Pypstra, R., & Solomkin, J. S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00551-07 · Cited by 191
USA300 Methicillin-Resistant Staphylococcus aureus, United States, 2000–2013
Carrel, M., Perencevich, E. N., & David, M. Z. (2015) · Emerging Infectious Diseases · doi:10.3201/eid2111.150452 · Cited by 185
Kolar, S. L., Antonio Ibarra, J., Rivera, F. E., Mootz, J. M., Davenport, J. E., Stevens, S. M., Horswill, A. R., & Shaw, L. N. (2013) · MicrobiologyOpen · doi:10.1002/mbo3.55 · Cited by 187
Diep, B. A., Palazzolo-Ballance, A. M., Tattevin, P., Basuino, L., Braughton, K. R., Whitney, A. R., Chen, L., Kreiswirth, B. N., Otto, M., DeLeo, F. R., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003198 · Cited by 188
Uhlemann, A.-C., Dordel, J., Knox, J. R., Raven, K. E., Parkhill, J., Holden, M. T. G., Peacock, S. J., & Lowy, F. D. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401006111 · Cited by 184
Calfee, D. P., Salgado, C. D., Classen, D., Arias, K. M., Podgorny, K., Anderson, D. J., Burstin, H., Coffin, S. E., Dubberke, E. R., Fraser, V., et al. (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591061 · Cited by 182
Yang, E. S., Tan, J., Eells, S., Rieg, G., Tagudar, G., & Miller, L. G. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02836.x · Cited by 183
“However, previous studies in this population at our institution have shown that >90% of CA-MRSA isolates are USA300 SCCmec Type IV-containing strains [22], the most commonly circulating CA-MRSA strain in the USA, whereas isolates of CA-MSSA are heterogeneous in terms of strain type [6].”
ResultHidron, A. I., Low, C. E., Honig, E. G., & Blumberg, H. M. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70133-1 · Cited by 180
Brubaker, A. L., Rendon, J. L., Ramirez, L., Choudhry, M. A., & Kovacs, E. J. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201213 · Cited by 181
Deep neck infections: a study of 365 cases highlighting recommendations for management and treatment
Boscolo-Rizzo, P., Stellin, M., Muzzi, E., Mantovani, M., Fuson, R., Lupato, V., Trabalzini, F., & Da Mosto, M. C. (2012) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-011-1761-1 · Cited by 168
Miragaia, M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02723 · Cited by 168
Blue 470-nm Light Kills Methicillin-Resistant Staphylococcus aureus (MRSA) in Vitro
Enwemeka, C. S., Williams, D., Enwemeka, S. K., Hollosi, S., & Yens, D. (2009) · Photomedicine and Laser Surgery · doi:10.1089/pho.2008.2413 · Cited by 176
Jenkins, T. C., Sabel, A. L., Sarcone, E. E., Price, C. S., Mehler, P. S., & Burman, W. J. (2010) · Clinical Infectious Diseases · doi:10.1086/656431 · Cited by 182
Otter, J. A., & French, G. L. (2011) · Journal of Hospital Infection · doi:10.1016/j.jhin.2011.04.028 · Cited by 175
Memmi, G., Filipe, S. R., Pinho, M. G., Fu, Z., & Cheung, A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00049-08 · Cited by 173
Staphylococcus aureus (Including Staphylococcal Toxic Shock)
QUE, Y.-A., & MOREILLON, P. (2010) · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases · doi:10.1016/b978-0-443-06839-3.00195-8 · Cited by 172
Wang, J.-L., Chen, S.-Y., Wang, J.-T., Wu, G. H.-M., Chiang, W.-C., Hsueh, P.-R., Chen, Y.-C., & Chang, S.-C. (2008) · Clinical Infectious Diseases · doi:10.1086/527389 · Cited by 174
Li, M., Cheung, G. Y. C., Hu, J., Wang, D., Joo, H., DeLeo, F. R., & Otto, M. (2010) · The Journal of Infectious Diseases · doi:10.1086/657419 · Cited by 175
“reported to emergency departments [8].”
BackgroundDiekema, D. J., Richter, S. S., Heilmann, K. P., Dohrn, C. L., Riahi, F., Tendolkar, S., McDanel, J. S., & Doern, G. V. (2014) · Infection Control & Hospital Epidemiology · doi:10.1086/675283 · Cited by 163
Monecke, S., Jatzwauk, L., Weber, S., Slickers, P., & Ehricht, R. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01986.x · Cited by 174
Treatment of Staphylococcus aureus Biofilm Infection by the Quorum-Sensing Inhibitor RIP
Balaban, N., Cirioni, O., Giacometti, A., Ghiselli, R., Braunstein, J. B., Silvestri, C., Mocchegiani, F., Saba, V., & Scalise, G. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01097-06 · Cited by 173
Worldwide Epidemiology and Antibiotic Resistance of Staphylococcus aureus
Monaco, M., de Araujo, F. P., Cruciani, M., Coccia, E. M., & Pantosti, A. (2016) · Current topics in microbiology and immunology · doi:10.1007/82_2016_3 · Cited by 202
Evaluation and Management of Septic Arthritis and its Mimics in the Emergency Department
Long, B., Koyfman, A., & Gottlieb, M. (2019) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2018.10.40974 · Cited by 169
Hota, B. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.10.1026 · Cited by 172
Paddock, C. D., Liu, L., Denison, A. M., Bartlett, J. H., Holman, R. C., DeLeon-Carnes, M., Emery, S. L., Drew, C. P., Shieh, W.-J., Uyeki, T. M., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir861 · Cited by 171
Jarvis, W. R., Jarvis, A. A., & Chinn, R. Y. (2012) · American Journal of Infection Control · doi:10.1016/j.ajic.2012.02.001 · Cited by 166
Thurlow, L. R., Joshi, G. S., & Richardson, A. R. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00937.x · Cited by 166
Innate and adaptive immune responses against Staphylococcus aureus skin infections
Krishna, S., & Miller, L. S. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0292-6 · Cited by 166
Corey, G. R., Wilcox, M. H., Talbot, G. H., Thye, D., Friedland, D., Baculik, T., on behalf of the CANVAS 1 investigators, Mehra, P., Alpert, M., Baird, I., et al. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq254 · Cited by 165
Outpatient parenteral antimicrobial therapy today
Paladino, J. A., & Poretz, D. (2010) · Clinical Infectious Diseases · doi:10.1086/653520 · Cited by 167
The Use and Abuse of Antibiotics and the Development of Antibiotic Resistance
English, B. K., & Gaur, A. H. (2010) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-0981-7_6 · Cited by 158
S. aureus drives itch and scratch-induced skin damage through a V8 protease-PAR1 axis
Deng, L., Costa, F., Blake, K. J., Choi, S., Chandrabalan, A., Yousuf, M. S., Shiers, S., Dubreuil, D., Vega-Mendoza, D., Rolland, C., et al. (2023) · Cell · doi:10.1016/j.cell.2023.10.019 · Cited by 159
Gorwitz, R. J. (2008) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31815819bb · Cited by 164
“study conducted in 2004.(40) In contrast, PVL genes rarely are found in MRSA PFTs more strongly associated with healthcare transmission.”
BackgroundInfluentialSelf-citationMcDougal, L. K., Fosheim, G. E., Nicholson, A., Bulens, S. N., Limbago, B. M., Shearer, J. E. S., Summers, A. O., & Patel, J. B. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00351-10 · Cited by 143
Self-citationManagement of Skin Abscesses in the Era of Methicillin-Resistant Staphylococcus aureus
Singer, A. J., & Talan, D. A. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1212788 · Cited by 160
Self-citationPan, W.-Y., Huang, C.-C., Lin, T.-T., Hu, H.-Y., Lin, W.-C., Li, M.-J., & Sung, H.-W. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.11.014 · Cited by 160
Chua, K., Laurent, F., Coombs, G., Grayson, M. L., & Howden, B. P. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq067 · Cited by 159
Suaya, J. A., Mera, R. M., Cassidy, A., O’Hara, P., Amrine-Madsen, H., Burstin, S., & Miller, L. G. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-296 · Cited by 153
A systematic review of bacteremias in cellulitis and erysipelas
Gunderson, C. G., & Martinello, R. A. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.11.004 · Cited by 160
Tsukatani, T., Suenaga, H., Shiga, M., Noguchi, K., Ishiyama, M., Ezoe, T., & Matsumoto, K. (2012) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2012.05.001 · Cited by 165
Leung, M. H. Y., Wilkins, D., & Lee, P. K. H. (2015) · Scientific Reports · doi:10.1038/srep11845 · Cited by 156
Polyamine Effects on Antibiotic Susceptibility in Bacteria
Kwon, D.-H., & Lu, C.-D. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01472-06 · Cited by 156
Ralston, E. P., Kite-Powell, H. L., & Beet, A. (2011) · Journal of Water and Health · doi:10.2166/wh.2011.157 · Cited by 157
Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity
Cassat, J. E., & Skaar, E. P. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0294-4 · Cited by 155
“It is the most common cause of skin and soft tissue infections [1, 2], endocarditis [3], and osteomyelitis [4] and a common cause of bloodstream infections, surgical site infections, and pneumonia.”
BackgroundStaphylococcus aureus infections: transmission within households and the community
Knox, J., Uhlemann, A., & Lowy, F. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.03.007 · Cited by 147
Lipsky, B. A., Weigelt, J. A., Gupta, V., Killian, A. D., & Peng, M. M. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/520743 · Cited by 155
Lacey, K., Geoghegan, J., & McLoughlin, R. (2016) · Pathogens · doi:10.3390/pathogens5010022 · Cited by 146
Staphylococcus aureus Community-Acquired Pneumonia During the 2006 to 2007 Influenza Season
Kallen, A. J., Brunkard, J., Moore, Z., Budge, P. J., Arnold, K. E., Fosheim, G. E., Finelli, L., Beekmann, S. E., Polgreen, P. M., Gorwitz, R. J., et al. (2008) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2008.04.027 · Cited by 178
Self-citationMethicillin-Resistant S. aureus Infections among Patients in the Emergency Department
THIERS, B. H. (2007) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)70416-7 · Cited by 154
Rivera, A. M., & Boucher, H. W. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2011.0514 · Cited by 178
Host–pathogen interactions between the skin and Staphylococcus aureus
Krishna, S., & Miller, L. S. (2012) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.11.003 · Cited by 147
Are pleuromutilin antibiotics finally fit for human use?
Novak, R. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06219.x · Cited by 160
The Role of β-Hemolytic Streptococci in Causing Diffuse, Nonculturable Cellulitis
Jeng, A., Beheshti, M., Li, J., & Nathan, R. V. (2010) · Medicine · doi:10.1097/md.0b013e3181e8d635 · Cited by 151
Campbell, S. J., Deshmukh, H. S., Nelson, C. L., Bae, I., Stryjewski, M. E., Federspiel, J. J., Tonthat, G. T., Rude, T. H., Barriere, S. L., Corey, R. G., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01822-07 · Cited by 168
Epidemiology of Staphylococcal Resistance
Shorr, A. F. (2007) · Clinical Infectious Diseases · doi:10.1086/519473 · Cited by 175
Metadata
- Authors
- Moran, G. J., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., McDougal, L. K., Carey, R. B., & Talan, D. A.
- Affiliations
- Olive View-UCLA Medical Center (US)
- Centers for Disease Control and Prevention (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-08-17
- Volume
- 355
- Issue
- 7
- Pages
- 666-674
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2131316809
- Cited by
- 2,285
- References
- 35
- Citations by year
- 2026: 28 · 2025: 39 · 2024: 58 · 2023: 39 · 2022: 42 · 2021: 55 · 2020: 57 · 2019: 76 · 2018: 83 · 2017: 72 · 2016: 93 · 2015: 125 · 2014: 117 · 2013: 145 · 2012: 170
- FWCI
- 138.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention (U01CI000353)
- U.S. Public Health Service (U50/CCU912342)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Health Sciences › Medicine › Infectious Diseases › Dermatological diseases and infestations
- Keywords
- methicillin-resistant Staphylococcus aureus, skin and soft tissue infections, emergency department patients, community-acquired MRSA, USA300, Panton-Valentine leukocidin, antibiotic susceptibility, empirical antibiotic therapy, antimicrobial resistance, methicillin-susceptible Staphylococcus aureus
- MeSH terms
- Acute Disease, Adult, Aged, Anti-Bacterial Agents, Bacterial Proteins, Bacterial Toxins, Emergency Service, Hospital, Exotoxins, Female, Humans, Leukocidins, Male, Microbial Sensitivity Tests, Middle Aged, Staphylococcal Infections, Staphylococcal Skin Infections, Staphylococcus aureus, United States, Methicillin Resistance, Electrophoresis, Gel, Pulsed-Field, Soft Tissue Infections, Penicillin-Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.